Eligibility Type 2 Diabetes NCT00508599

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetic for at least 6 months.
Descrizione

Non-Insulin-Dependent Diabetes Mellitus disease length

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0872146
healthy volunteers.
Descrizione

Healthy Volunteers

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1708335
type 2 diabetic subjects will have some nominal ability to secrete endogenous insulin as demonstrated by a post-stimulation c-peptide concentration of at least 6 ng/ml.
Descrizione

Diabetes Mellitus, Non-Insulin-Dependent | insulin secretion | C-peptide measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C1256369
UMLS CUI [3]
C0202100
all subjects will be mentally fit to give informed consent.
Descrizione

Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
hemoglobin a1c value below 11% (normal range = 4.4-5.8%) prior to study enrollment.
Descrizione

Glucohemoglobin measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0202054
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
hemoglobin a1c values > 11%
Descrizione

Glycosylated haemoglobin increased

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019018
severe cardiovascular, hepatic, or renal disease
Descrizione

Cardiovascular Disease Severe | Liver disease Severe | Kidney Disease Severe

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0023895
UMLS CUI [2,2]
C0205082
UMLS CUI [3,1]
C0022658
UMLS CUI [3,2]
C0205082
past current history of drug or alcohol abuse
Descrizione

Substance Use Disorders

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0038586
diabetic gastroparesis
Descrizione

Gastroparesis due to diabetes mellitus

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0267176
uncontrolled hypertension ( > 140-90 mmhg)
Descrizione

Uncontrolled hypertension

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1868885
marked hyperlipidemia (serum ldl > 158mg/dl, or serum tg >691 mg/dl)
Descrizione

Hyperlipidemia Marked | serum LDL | Serum thyroglobulin level

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020473
UMLS CUI [1,2]
C1706089
UMLS CUI [2]
C0036816
UMLS CUI [3]
C1271701
medications that interfere with glucose homeostasis
Descrizione

Pharmaceutical Preparations Interfere with Glucose homeostasis

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C1326961
coumadin or other anticoagulation medications
Descrizione

Coumadin | Anticoagulants

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0699129
UMLS CUI [2]
C0003280
history of thrombosis or thrombophlebitis
Descrizione

Thrombosis | Thrombophlebitis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0040053
UMLS CUI [2]
C0040046
current malignancy
Descrizione

Malignant Neoplasms

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0006826
smoker
Descrizione

Tobacco use

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0543414
pregnancy
Descrizione

Pregnancy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
contact precautions
Descrizione

Contact precautions

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1443873

Similar models

Eligibility Type 2 Diabetes NCT00508599

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Non-Insulin-Dependent Diabetes Mellitus disease length
Item
type 2 diabetic for at least 6 months.
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Healthy Volunteers
Item
healthy volunteers.
boolean
C1708335 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent | insulin secretion | C-peptide measurement
Item
type 2 diabetic subjects will have some nominal ability to secrete endogenous insulin as demonstrated by a post-stimulation c-peptide concentration of at least 6 ng/ml.
boolean
C0011860 (UMLS CUI [1])
C1256369 (UMLS CUI [2])
C0202100 (UMLS CUI [3])
Informed Consent
Item
all subjects will be mentally fit to give informed consent.
boolean
C0021430 (UMLS CUI [1])
Glucohemoglobin measurement
Item
hemoglobin a1c value below 11% (normal range = 4.4-5.8%) prior to study enrollment.
boolean
C0202054 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Glycosylated haemoglobin increased
Item
hemoglobin a1c values > 11%
boolean
C0019018 (UMLS CUI [1])
Cardiovascular Disease Severe | Liver disease Severe | Kidney Disease Severe
Item
severe cardiovascular, hepatic, or renal disease
boolean
C0007222 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0023895 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0022658 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
Substance Use Disorders
Item
past current history of drug or alcohol abuse
boolean
C0038586 (UMLS CUI [1])
Gastroparesis due to diabetes mellitus
Item
diabetic gastroparesis
boolean
C0267176 (UMLS CUI [1])
Uncontrolled hypertension
Item
uncontrolled hypertension ( > 140-90 mmhg)
boolean
C1868885 (UMLS CUI [1])
Hyperlipidemia Marked | serum LDL | Serum thyroglobulin level
Item
marked hyperlipidemia (serum ldl > 158mg/dl, or serum tg >691 mg/dl)
boolean
C0020473 (UMLS CUI [1,1])
C1706089 (UMLS CUI [1,2])
C0036816 (UMLS CUI [2])
C1271701 (UMLS CUI [3])
Pharmaceutical Preparations Interfere with Glucose homeostasis
Item
medications that interfere with glucose homeostasis
boolean
C0013227 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C1326961 (UMLS CUI [1,3])
Coumadin | Anticoagulants
Item
coumadin or other anticoagulation medications
boolean
C0699129 (UMLS CUI [1])
C0003280 (UMLS CUI [2])
Thrombosis | Thrombophlebitis
Item
history of thrombosis or thrombophlebitis
boolean
C0040053 (UMLS CUI [1])
C0040046 (UMLS CUI [2])
Malignant Neoplasms
Item
current malignancy
boolean
C0006826 (UMLS CUI [1])
Tobacco use
Item
smoker
boolean
C0543414 (UMLS CUI [1])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Contact precautions
Item
contact precautions
boolean
C1443873 (UMLS CUI [1])